this study was to investigate the plaque endothelial local permeability in the ApoE-/- mouse model with optical imaging using fluorescent blood pool agents. Methods: A human serum albumin conjugated with
SOX2, KLF4 and Nanog. Using the HA-treated spheroid, we established an experimental xenograft mouse model with high angiogenesis enhanced tumor-initiating capacity while retaining the glioblastoma traits. Conclusion…
done to characterize the obtained phytosterols. Letrozole (0.5 mg/kg body weight) induced PCOS mouse model was fed orally with the isolated phytosterol for 60 days. After completion ... beta-sitosterol, stigmasterol and…
treatment would prevent development and reduce the severity of T1D in an experimental mouse model, low-dose Streptozotocin (STZ)-induced autoimmune T1D, by affecting pathogenic T-cells. Aqueous- and ethanol
risk of EA progression. The aim of this study was to produce a mouse model of BE, suitable for further molecular and genetic analyses. Methods: Forty-four CD1 mice were
these receptors has been shown to provide neuroprotection in multiple sclerosis and in mouse model of AlzheimerâÂ?Â?s disease. Whether the selective sphingosine-1-phosphate receptors modulator FTY720 exhibits
decreased diaphragm muscle contraction, increased NOS activity, IL-4 levels of diaphragm in a mouse model. Budesonide/Formoterol combination could protect diaphragm muscle weakness and inflammation. According to the…
Western blotting was performed on protein samples extracted from ventral midbrain. Results: In a mouse model of PD induced by sub-acute administration of 1-methyl-4-phenyl
present study we explored whether the release of HMGB1 in our mouse model of PD caused the activation of the NLRP3 (NOD-like Receptor Protein 3) positive inflammasome. NLRP3-inflammasome
Western blotting was performed on protein samples extracted from ventral midbrain. Results: In a mouse model of PD induced by sub-acute administration of 1-methyl-4-phenyl
platform we demonstrate that NLRX1 and NLRP12 inhibit progression of the diseases in a mouse model of MS. We observed reduced inflammation and improve biochemical and behavioral outcomes
transgenes) mice models of AlzheimerâÂ?Â?s disease. Oral treatment of natural compound reversed transgene-associated behavioral deficits, but did not alter wild-type mouse behaviors. Furthermore, brain AÃ?² depositions
platform we demonstrate that NLRX1 and NLRP12 inhibit progression of the diseases in a mouse model of MS. We observed reduced inflammation and improve biochemical and behavioral outcomes
trachea, eye conjunctiva and vagina. As proof of concept that the mouse strain was a valuable preclinical model, we first showed that Muc5b production greatly varied during estrous cycle ... with chemically-induced dry…
above research conclusions, the animal experiments were conducted in combination with an SLE model mouse with BCG vaccinations. Results: The research results showed that, for the mice receiving BCG vaccinations